Carina Biotech Symposium 2022 Program
Carina Biotech Symposium Program Wednesday, 18 May 2022 Hotel Grand Chancellor Adelaide + online Join from a PC, Mac, iOS
Carina Biotech inaugural symposium to be held on 18 May 2022 in Adelaide and virtually
PLEASE JOIN US on Wednesday, 18 May 2022 9:30 am – 5:00 pm for Carina Biotech's inaugural symposium Join us
Carina Biotech to showcase its LGR5 CAR-T program at the American Association for Cancer Research (AACR) Annual Meeting
Carina has had five abstracts accepted for poster presentations at the AACR Annual Meeting which will take place from April
Carina Biotech submits LGR5 CAR-T pre-IND (Investigational New Drug) package to the US Food & Drug Administration
Carina Biotech is very pleased to announce that we have submitted a pre-IND (Investigational New Drug) application to the US FDA (Food
5 Biggest Biotech Trends in 2022
In Forbes' 5 Biggest Biotech Trends for 2022, top of the list is personalised medicine – of which CAR-T therapy
Carina Biotech licenses German technology to create highly efficient CAR-T cells targeting hard-to-treat cancers
Carina Biotech has entered a license agreement with Bayerische Patentallianz (BayPAT) to the CXCR6-transduced CAR-T cell technology developed at the
Manufacture of Carina’s LGR5 CAR-T has begun with CellVec contracted to produce GMP-grade lentivirus constructs
Singapore-based CellVec will manufacture clinical-grade lentivirus – the first critical step in making LGR5 CAR-T cells for a first-in-human clinical
Carina Biotech raises $5.4 million to ready LGR5 CAR-T program for advanced colorectal cancer for the clinic
Carina Biotech is delighted to announce it has raised AU$5.4 million. The raise was strongly supported by current shareholders, board and